Edition:
India

Cortexyme Inc (CRTX.OQ)

CRTX.OQ on NASDAQ Stock Exchange Global Select Market

26.98USD
20 Sep 2019
Change (% chg)

$2.99 (+12.46%)
Prev Close
$23.99
Open
$24.37
Day's High
$26.98
Day's Low
$24.03
Volume
26,901
Avg. Vol
24,089
52-wk High
$47.00
52-wk Low
$19.35

Summary

Name Age Since Current Position

Casey Lynch

Chief Executive Officer, Co-Founder, Director

Steve Dominy

Co-Founder, Chief Scientific Officer, Director

Kristen Gafric

Co-Founder, SVP Legal & Administration

Christopher Lowe

48 Chief Financial Officer

Leslie Holsinger

50 2018 Executive Vice President, Preclinical Development

Biographies

Name Description

Casey Lynch

Ms. Casey Lynch is a Chief Executive Officer, Co-Founder and Board of Director of the company.Casey also served as Founder & Managing Director NeuroInsights. Previously CEO Aspira Biosystems, New Opportunities/Animal models Centaur Pharma, Alzheimer’s research at UCSF, Stanford, Wadsworth VA

Steve Dominy

Mr. Steve Dominy M.D., is a Co-Founder, Chief Scientific Officer, Director of the Company. He served Division Director San Francisco General Hospital, Associate Professor UCSF, discover of novel therapeutic target for AD and other disorders.

Kristen Gafric

Ms.Kristen Gafric J.D. is Co-Founder, SVP Legal & Administration of Company.She served UCSF Contracts and Grants, San Francisco Health Plan Contracts Manager, Triton Commercial Contracts

Christopher Lowe

Mr.Christopher P. Lowe is Chief Financial Officer of Company.He served as CFO & CBO Anthera Pharmaceuticals, VP & CAO Peninsula Pharmaceuticals, Interim CEO Hansen Medical, VP and CFO Asthmatix, Director at Inspyr and Epibiome

Leslie Holsinger

Dr. Leslie Holsinger is a Executive Vice President, Preclinical Development of the company. Previously she served as rev. VP Biology at Virobay developing cathepsin inhibitors for neuropathic pain, autoimmune disease, fibrosis, and Alzheimer's. Associate Director of Cell Biology at Celera, Group Leader at Sugen.

Basic Compensation

Options Compensation